...
首页> 外文期刊>Journal of Infectious Diseases >Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor γ Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction
【24h】

Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor γ Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction

机译:罗格列酮对人脂肪组织中过氧化物酶体增殖物激活的受体γ基因表达的影响受抗逆转录病毒药物诱导的线粒体功能障碍的限制

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Treatment of human immunodeficiency virus (HIV)-1 with thymidine-analogue nucleoside reverse-transcriptase inhibitors (tNRTIs) causes lipoatrophy, mitochondrial toxicity, and lower adipose tissue expression of peroxisome proliferator-activated receptor γ (PPARγ [PPARG gene]) . Rosiglitazone (RSG), a PPARγ agonist, improves congenital lipoatrophy but not HIV lipoatrophy.
机译:背景。用胸苷类似物核苷逆转录酶抑制剂(tNRTIs)治疗人免疫缺陷病毒(HIV)-1会导致脂肪萎缩,线粒体毒性和过氧化物酶体增殖物激活受体γ(PPARγ[PPARG基因])的脂肪组织表达降低。罗格列酮(RSG)是PPARγ激动剂,可改善先天性脂肪萎缩,但不能改善HIV脂肪萎缩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号